Wellington Management Group
ASPX

Wellington Management Group’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Wellington Management Group’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,840
Closed -$359K – 2299
2014
Q4 		$359K Buy
+6,840
New +$201K ﹤0.01% 2056
2014
Q3 		– Sell
-91,800
Closed -$2.04M – 2306
2014
Q2 		$2.04M Sell
91,800
-12,410
-12% -$271K ﹤0.01% 1677
2014
Q1 		$3.21M Buy
+104,210
New +$2.8M ﹤0.01% 1581

Other funds holding ASPX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group's ASPX Position: Q1 2015 in Review

Wellington Management Group sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q1 2015, closing a stake of 6,840 shares — an estimated $359K sold.

Wellington Management Group first reported a position in ASPX in Q1 2014 and held it in 3 quarters. The position peaked at $3.21M in Q1 2014. 138 funds tracked by Wall St. Rank hold ASPX as of Q1 2015.

  • Wellington Management Group reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Wellington Management Group sold 6,840 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $359K.
  • Wellington Management Group first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 3 quarters.
  • Wellington Management Group's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $3.21M in Q1 2014.
  • 138 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on Wellington Management Group's 13F filing for Q1 2015, filed 15 May 2015.